Mental health refers to cognitive, behavioral, and emotional well-being. It is all about how people think, feel, and behave.
People with severe mental illnesses, such as schizophrenia, face many challenges related to accessing community mental health services and adherence to medication regimen. The advent of Long‐Acting Injectable antipsychotics (LAIs) promises to increase compliance with medication therapy. The purpose of this study is to examine retrospective and prospective data to understand the impact of the use of LAIs among people living with schizophrenia who are Medicaid beneficiaries.